體外診斷 (IVD) 趨勢與市場最新形勢 (2022年11月)

診斷測試產品比以往都重要。檢驗需求和現行技術、新技術的動向，在體外診斷用醫藥品市場大部分的領域持續取得進展。新產品和全球醫療支出的變化，主要市場上法規的變更，疾病趨勢的要素，持續刷新市場透視。市場中也有引起產業注目的成長領域。其中有新一代定序 (NGS)，個人化醫療，質譜分析等。還有免疫化學，照護現場 (POC) 檢驗，分子診斷學市場關心也高，成為IVD的未來中核的領域。體外診斷用醫藥品市場，由於不斷的技術創新，繼續動態的動向。

本報告提供全球體外診斷 (IVD) 市場最新趨勢 (2022年11月現在) 相關分析，整體市場規模趨勢預測，及市場主要促進、阻礙因素 (2022年第3季及下半年)，新產品的開發、銷售趨勢，新型冠狀病毒感染疾病 (COVID-19) 的影響，今後的產品開發、市場開拓的可能性等彙整資訊，為您概述為以下內容。

目錄

第1章 全球IVD市場 (2022年11月更新)

• IVD市場需求與成長
• COVID-19診斷市場
• COVID-19對市場區隔的影響

第2章 產品趨勢與新開發

• 主要的新產品 (2022年第3季):核心IVD產品的銷售、開發、趨勢
• 臨床化學
• 流式細胞技術
• 免疫測量
• 質譜分析
• 分子
• 個人化醫療
• POC
• 定序
• 新型冠狀病毒感染疾病 (COVID-19) 相關的主要趨勢 (2022年第3季)
• 抗原、抗體
• 分子

第3章 大IVD企業的業績

• 主要的競爭領導者的最新趨勢
• 第3季的企業合併、收購 (M&A) 活動
• Abbott Laboratories
• Becton Dickinson and Co
• bioMérieux SA
• Danaher Corporation
• Hologic, Inc.
• QuidelOrtho Corporation
• Roche Diagnostic
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific

第4章 新機會

• 人工智慧的今後趨勢
• 家庭檢驗
• IVD的微射流
• 遠程醫療

Key Questions answered in this report:

• What's Driving Growth in the IVD Market in Q3 and the last half of 2022?

• What Major Trends are Affecting the Market in Q3 and the last half of 2022?

• How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2022?

• What Product Trends and New Developments Will Shape the IVD Market in the last half of 2022?

Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information as of Q3 2022 with a publication date of November 2022.

The demand for testing and movement of current and new technologies has continued to demonstrate gains in most areas of the IVD market. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly evolving market picture. There are some growing segments in the market that have attracted industry attention. Among these are next-generation sequencing (NGS), personalized medicine and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also segments of great market interest, anticipated to be a core part of the future of IVD. The IVD market remains dynamic, demonstrating constant innovations.

Kalorama Information continues to be diligent in outlining the IVD market and its rapidly changing landscape. Kalorama Information has been and continues to be superior in accessing the market due to the extensive experience of its authors and commitment by the company to present the most accurate data available.

Table of Contents

Chapter 1: Worldwide IVD Market - November 2022 Update

• IVD Market Demand and Growth
  • Figure 1-1: Quarter-by-Quarter Segment Performance Commentary, 2022
  • Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2022 ($ million) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
  • Figure 1-2: IVD Segment Performance, Q1 2022 - Q4 2022e ($MN)
  • Figure 1-3: IVD Segment Performance, Total Market Value, 2022 ($MN)
• COVID-19 Diagnostic Markets
  • Table 1-2: COVID-19 Product Sales - Immunoassay (Antigen, Serology), Molecular, Rapid - 2022 ($ millions)
• Effect of COVID-19 on Market Segments
  • Table 1-3: IVD Market excluding and with COVID-19, 2022
  • Figure 1-4: IVD Market Distribution by Segment, 2022
  • Figure 1-5: IVD Market by COVID-19 and non-COVID markets, Quarterly Performance, 2022
  • Table 1-4: Global In Vitro Diagnostic Market - YoY Growth 2021-2022
  • Figure 1-6: Global In Vitro Diagnostic Market - YoY Growth 2021-2022

Chapter 2: Product Trends and New Developments

• Selected New - Q3 2022 - Core IVD Product Launches, Developments and Trends
• Clinical Chemistry
• Flow Cytometry
• Immunoassay
• Mass Spectrometry
• Molecular
• Personalized Medicine
• POC
• Sequencing
• Selected COVID-19 Developments - Q3 2022
  • Figure 2-1: COVID-19 Test Market by Type, Q1-Q3 2022 - COVID-19 Testing Wanes
• Antigen/Antibody
• Molecular

Chapter 3: Top IVD Market Participant Results

• Selected Competitive Leader Updates
  • Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2021-2022
  • Figure 3-2: Changes in Market Distribution for IVD Sales, 2019 - 2022 - Roche and Abbott Battle for #1 Spot
  • Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche 2020-2022 (in millions $)
• Q3 M&A Activity
  • Table 3-1: IVD-Relevant M&A Activity, 2022
  • Figure 3-4: Count of IVD Industry M&A Deals by Month, 2022
• Abbott Laboratories
  • Table 3-2: Abbott Corporate Summary
• Becton Dickinson and Co
  • Table 3-3: Becton Dickinson Corporate Summary
• bioMérieux SA
  • Table 3-4: bioMérieux Corporate Summary
• Danaher Corporation
  • Table 3-5: Danaher Corporation Summary
• Hologic, Inc.
  • Table 3-6: Hologic Corporate Summary
• QuidelOrtho Corporation
  • Table 3-7: QuidelOrtho Corporate Summary
• Roche Diagnostic
  • Table 3-8: Roche Diagnostic Corporate Summary
• Siemens Healthineers
  • Table 3-9: Siemens Healthineers Corporate Summary
• Sysmex Corporation
  • Table 3-10: Sysmex Corporate Summary
• Thermo Fisher Scientific
  • Table 3-11: Thermo Fisher Scientific Corporate Summary

Chapter 4: New Opportunities

• Artificial Intelligence Future Trends
• At-Home Testing
• Microfluidics in IVD
• Telehealth